Skip to main content

Effects of anticoagulants on the activity of gelatinases.

Castellazzi M, Tamborino C, Fainardi E, Manfrinato MC, Granieri E, Dallocchio F, Bellini T

Publication: Clin Biochem (2007) • Vol 40 • Page 1272-6PMID: 17904541View on PubMed

Purpose

The purpose of this paper was to determine the effects of anticoagulants on the activity of matrix metalloproteinase (MMP)-2 and 9 in plasma and serum.

Conclusion

The average concentrations of MMP-2 and MMP-9 were highest in EDTA-plasma followed by serum and citrated plasma, which had similar levels to each other. Heparinated plasma had the lowest levels of MMP-2 and MMP-9. Treatment of pooled serum with EDTA resulted in significantly increased active MMP-2 and MMP-9 levels, while treatment of pooled serum with heparin resulted in significantly decreased activity for both enzymes. Treatment of pooled serum with citrate resulted in much smaller changes in levels of active MMP-2 and MMP-9.

Studies (1)

Purpose

The purpose of this study was to determine the effects of anticoagulants on the activity of MMP-2 and MMP-9 in plasma and serum from healthy volunteers. In addition to assaying individual and pooled serum specimens collected in plain tubes, pooled serum specimens that had been transferred to the blood collection tubes containing anticoagulants were assayed. Serum and plasma were aliquoted and stored at -70 degrees C until assay.

Summary of Findings

The average concentrations of MMP-2 and MMP-9 were significantly higher in K2EDTA-plasma than in serum (p<0.0001, and p<0.01, respectively), heparinated plasma (both p<0.0001), or citrated plasma (p<0.0001, and p<0.01, respectively). Heparinated plasma had lower average levels of MMP-2 and MMP-9 than serum (p<0.0001 and p<0.05, respectively), or citrated plasma (p<0.0001 and p<0.01, respectively), which did not have significantly different average MMP-2 or MMP-9 levels from one another. Treatment of pooled serum with K2EDTA resulted in significantly increased active MMP-2 (+640.2%) and MMP-9 levels (+150.6%), while treatment of pooled serum with heparin resulted in significantly decreased activity for both enzymes (-51.4% and -62.6%, respectively) compared to untreated pooled serum. Treatment of pooled serum with citrate resulted in much smaller changes in levels of active MMP-2 (-14.0%) and MMP-9 (+10.4%).

  • Biospecimens

    FluidPlasma
    FluidSerum
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
  • Platforms

    ProteinEnzyme assay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    Lithium heparin
    None
    Potassium EDTA
    Sodium citrate
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum